Friday, April 25, 2008

Global Conference on Methamphetamine Speaker & Program Update

Prague, Czech Republic 15th – 16th September 2008

The 1st global conference on methamphetamine has been organized in response to an emerging consensus among experts that methamphetamine use is a complex problem that presents a significant challenge to existing philosophies and strategies. While local and national communities are under siege by a perceived methamphetamine epidemic rush to pursue solutions, many facets of the problem remain to be discovered, examined, debated, illuminated and verified.

It is in this spirit of discovery, discussion, and cooperation that this conference is being convened. As the first event to gather global experts from varied fields, with diverse and even sometimes divergent perspectives, the conference is assured to be an unparalleled event!

Early registration for the 2008 global conference on methamphetamine is now open! Delegates are encouraged to register before June 1st, 2008 to qualify for the reduced pre-conference rate!

For more information, including details on registration, submitting abstracts, hotel and travel, visit: www.globalmethconference.com

Major and Concurrent Session Topics

Regional Updates / Pharmacology / Enforcement Programs / Clandestine Drug Cleanup / The Matrix Model of Treatment / Women and Methamphetamine / Latest Research /Health Consequences / Policy / Prosecution Issues / Trafficking / Toxicology / Innovative Interventions / Replacement Therapies / Prevention and Education / Hepatitis A, B, & C Virus / HIV Risk Behavior / Methamphetamine and Reproductive Health / Treatment / Youth and Use / Patterns of Use / Harm Reduction / innovative Interventions / Use Among MSM / Trafficking / Community-based Coalitions / Injection Drug Use / Epidemiology




Featured Speakers to include
:


Dr. Richard Rawson, UCLA Integrated Substance Abuse Programs, Los Angeles
Dr. Alex Wodak, MD Director, Alcohol and Drug Services Vincent's Hospital, Sydney
Dr. Carl Hart, Professor, Neuroscience Department of Psychiatry, Columbia University, New York
Andreas Plüddemann, Senior Scientist, Alcohol & Drug Abuse Research Unit Medical, Cape Town
Prof. Lin Lu, MD, PhD Director of National Institute of Drugs and Development, Beijing
Dr Apinun Aramrattana, MD, PhD Faculty of Medicine, Chiang Mai University, Chiang Mai
Donald Rothenbaum, Senior Vice President, Network Environmental Systems, San Diego
Kasia Malinowska-Sempruch, Director, Open Society's Institute's Global Drug Policy Program, Warsaw
Prof. Evgeny Krupitsky, MD, PhD St. Bekhterev Research Psychoneurological Institute, St. Petersburg
Dr. Tomas Zabransky, MD, PhD Manager Centre for Addictology, Charles University, Prague
Dr. Michael Siever, Director, The Stonewall Project, San Francisco
Caitlin Padgett, Coordinator and Founder of Youth R.I.S.E., Vancouver
Dr. Gady Zabicky, MD Centro Nacional para la Prevención y Control del VIH/SIDA (CENSIDA), Mexico City

No comments: